Who invested in Celularity

3 rounds we have observed, with the 11 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Raised 2 months ago

Funding summaryUpdated 26 Oct 2026

$270Mraised across 3 rounds since 2018, from 3 sources

$250MRound$10MDebt$10MDebt

Latest round: Debt, $10MSept 2026
Biggest round: $250MRound · Feb 2018
Investors: 11

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20182020202220242026

$250MRound$10MDebt$10MDebt

First round: Round, $250M
Biggest round: $250M
Usual gap between rounds: 7.8 years

The rounds

Sept 2026
Debt$10M1 new2 returning
Source recorded
Dec 2025
Debt$10M2 new
- Alumni Ventures
- S32
Source recordedSEC filing: $2.0M sold, first sale Oct 2025
Feb 2018
Round$250M8 new
- Celgene
- Section 32
- Genting Ventures
- Heritage
- United Therapeutics
- Dreyfus Family
- Homan Longevity
- Sorrento
Reported by FinSMEs

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Round2018Debt2025Debt2026

United TherapeuticsDreyfus FamilyHoman Longevity

Everyone who backed them

Alumni VenturesVC firm2rounds

S32VC firm2rounds

UNITED, Inc.Hedge fund1round

CelgeneGrowth equity1round

Section 32VC firm1round

Genting VenturesCorporate VC1round

HeritageHedge fund1round

United TherapeuticsInvestment firm1round

Dreyfus Familyno record of our own yet1round

Homan Longevityno record of our own yet1round

Sorrentono record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Celularity as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.